| The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site GM Anstead, KE Carlson, JA Katzenellenbogen Steroids 62 (3), 268-303, 1997 | 823 | 1997 |
| Posaconazole as salvage therapy for zygomycosis RN Greenberg, K Mullane, JAH Van Burik, I Raad, MJ Abzug, G Anstead, ... Antimicrobial Agents and Chemotherapy 50 (1), 126-133, 2006 | 702 | 2006 |
| Steroids, retinoids, and wound healing GM Anstead Advances in Skin & Wound Care 11 (6), 277-286, 1998 | 363 | 1998 |
| Malnutrition Alters the Innate Immune Response and Increases Early Visceralization following Leishmania donovani Infection GM Anstead, B Chandrasekar, W Zhao, JUE Yang, LE Perez, PC Melby Infection and Immunity 69 (8), 4709-4718, 2001 | 248 | 2001 |
| Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection DJ Skiest, JA Vazquez, GM Anstead, JR Graybill, J Reynes, D Ward, ... Clinical infectious diseases 44 (4), 607-614, 2007 | 197 | 2007 |
| Refractory coccidioidomycosis treated with posaconazole GM Anstead, G Corcoran, J Lewis, D Berg, JR Graybill Clinical infectious diseases 40 (12), 1770-1776, 2005 | 161 | 2005 |
| 2-Arylindenes and 2-arylindenones: molecular structures and considerations in the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor GM Anstead, SR Wilson, JA Katzenellenbogen Journal of medicinal chemistry 32 (9), 2163-2171, 1989 | 151 | 1989 |
| Hyperconjugative effects on carbon—Carbon bond lengths in molecular mechanics (MM4) NL Allinger, K Chen, JA Katzenellenbogen, SR Wilson, GM Anstead Journal of Computational Chemistry 17 (5‐6), 747-755, 1996 | 135 | 1996 |
| Posaconazole therapy for chronic refractory coccidioidomycosis DA Stevens, A Rendon, V Gaona-Flores, A Catanzaro, GM Anstead, ... Chest 132 (3), 952-958, 2007 | 124 | 2007 |
| Phenytoin in wound healing GM Anstead, LM Hart, JF Sunahara, ME Liter Annals of Pharmacotherapy 30 (7-8), 768-775, 1996 | 115 | 1996 |
| Coccidioidomycosis GM Anstead, JR Graybill Infectious Disease Clinics 20 (3), 621-643, 2006 | 94 | 2006 |
| Recent advances in the treatment of infections due to resistant Staphylococcus aureus GM Anstead, AD Owens Current opinion in infectious diseases 17 (6), 549-555, 2004 | 93 | 2004 |
| Adiaspiromycosis causing respiratory failure and a review of human infections due to Emmonsia and Chrysosporium spp GM Anstead, DA Sutton, JR Graybill Journal of Clinical Microbiology 50 (4), 1346-1354, 2012 | 90 | 2012 |
| 2, 3-Diarylindenes and 2, 3-diarylindenones: synthesis, molecular structure, photochemistry, estrogen receptor binding affinity, and comparisons with related triarylethylenes GM Anstead, RJ Altenbach, SR Wilson, JA Katzenellenbogen Journal of medicinal chemistry 31 (7), 1316-1326, 1988 | 83 | 1988 |
| 2-Arylindenes and 2-arylindenones. Synthesis of probes to study the binding orientation of unsymmetrical nonsteroidal ligands to the estrogen receptor GM Anstead, JL Ensign, CS Peterson, JA Katzenellenbogen The Journal of Organic Chemistry 54 (7), 1485-1491, 1989 | 75 | 1989 |
| The centenary of the discovery of trench fever, an emerging infectious disease of World War 1 GM Anstead The Lancet Infectious Diseases 16 (8), e164-e172, 2016 | 73 | 2016 |
| Multinutrient undernutrition dysregulates the resident macrophage proinflammatory cytokine network, nuclear factor-κB activation, and nitric oxide production GM Anstead, B Chandrasekar, Q Zhang, PC Melby Journal of Leucocyte Biology 74 (6), 982-991, 2003 | 64 | 2003 |
| Donor-acceptor tetrahydrochrysenes, inherently fluorescent, high-affinity ligands for the estrogen receptor: binding and fluorescence characteristics and fluorometric assay of … KJ Hwang, KE Carlson, GM Anstead, JA Katzenellenbogen Biochemistry 31 (46), 11536-11545, 1992 | 64 | 1992 |
| High risk of obesity and weight gain for HIV-infected uninsured minorities BS Taylor, Y Liang, LS Garduño, EA Walter, MB Gerardi, GM Anstead, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 65 (2), e33-e40, 2014 | 61 | 2014 |
| Treatment of Infections Due to Resistant Staphylococcus aureus GM Anstead, J Cadena, H Javeri Methicillin-Resistant Staphylococcus Aureus (MRSA) Protocols, 259-309, 2014 | 60 | 2014 |
